Profile: Helsinn Healthcare S.A. specializes in offering pharmaceuticals and medical devices. Our products include cancer supportive care products, pain & inflammation and gastroenterology products. Palonosetron (palonosetron hydrochloride) is a second generation 5-HT3 receptor antagonist developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with cancer, with a long half-life of 40 hours & at least 30 times higher receptor binding affinity than currently available compounds.
FDA Registration Number: 3004642655
US Agent: Jason Najdzinowicz / Helsinn Therapeutics (us) Inc.
Phone: +1-(732)-603-2842 E-Mail:
2 Products/Services (Click for related suppliers)
|
• Drug Wound Dressing (FDA Code: FRO) |
• Hydrogel Wound and Burn Dressing (FDA Code: MGQ) |